Pages that link to "Item:Q5866135"

The following pages link to A Bayesian adaptive design for addressing correlated late-onset outcomes in phase I/II randomized trials of drug combinations in oncology (Q5866135):

Displaying 7 items.

• Bayesian phase I/II adaptively randomized oncology trials with combined drugs (Q641145) (← links)
• Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity (Q746098) (← links)
• Adaptive oncology Phase I trial design of drug combinations with drug-drug interaction modeling (Q1782097) (← links)
• A phase I-II basket trial design to optimize dose-schedule regimes based on delayed outcomes (Q2057378) (← links)
• Application of gamma process to two-agent combinations with delayed toxicity (Q5083969) (← links)
• A Bayesian seamless phase I–II trial design with two stages for cancer clinical trials with drug combinations (Q5135528) (← links)
• A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes (Q6076490) (← links)